Australia's Next Science up on license approval from Canada health department

Next Science

26/08/2022 06:45

** Shares of Next Science  NXS.AX  gain as much as 4.5% to
A$0.935, seeing their best since Aug 16
    ** The medical technologies co says Canada's health
department has given licensing approval for co's irrigation
product, XPERIENCE, to be sold in the country  urn:newsml:reuters.com:*:nFWN3012C9
    ** Says co is working on plans to launch XPERIENCE in the
Canadian market during H2 2022
    ** Stock has fallen 28.1% this year, as of last close

 (Reporting by Archishma Iyer)
 ((Archishma.Iyer@thomsonreuters.com;))